We are live on ! Find out more
TCAC

Tuatara Capital Acquisition Corporation Class A Ordinary Shares

Delisted

TCAC was delisted on the 14th of June, 2022.

0 hedge funds and large institutions have $0 invested in Tuatara Capital Acquisition Corporation Class A Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 670 (-67)

100% less capital invested

Capital invested by funds: $176M → $0 (-$176M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 67

Holders
Holders Change
-67
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
67
Calls
Puts
Net Calls
Net Calls Change

TCAC Hedge Fund Activity: Q2 2022 in Review

0 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Tuatara Capital Acquisition Corporation Class A Ordinary Shares (TCAC) for Q2 2022, worth a combined $0 — down 100% from $176M a quarter earlier.

Sellers outnumbered buyers: 67 funds closed out of TCAC and 0 opened new positions — a net loss of 67 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Aristeia Capital, exiting entirely with an estimated $10.3M sold.

  • 0 institutional investors held Tuatara Capital Acquisition Corporation Class A Ordinary Shares (TCAC) as of Q2 2022, down from 67 in Q1 2022.
  • Funds reported $0 of Tuatara Capital Acquisition Corporation Class A Ordinary Shares stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Tuatara Capital Acquisition Corporation Class A Ordinary Shares positions in Q2 2022 and 67 closed out, a net change of -67 holders.
  • The largest Tuatara Capital Acquisition Corporation Class A Ordinary Shares seller in Q2 2022 was Aristeia Capital, an estimated $10.3M sold.

Based on aggregated 13F filings for Q2 2022.